Effectiveness and Serotype Coverage: Key Criteria for Pneumococcal Vaccines for Adults

Epidemiology of Streptococcus pneumoniae in France before introduction of the PCV-13 vaccine

(2011) N. Grall et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe

(2011) David S Fedson et al.   Expert Review of Vaccines

Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults

(2011) Daniel M. Musher et al.   Human vaccines & immunotherapeutics

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

(2011) Elizabeth Miller et al.   LANCET INFECTIOUS DISEASES

Risk of Red Queen dynamics in pneumococcal vaccine strategy

(2011) Johanna M.C. Jefferies et al.   TRENDS IN MICROBIOLOGY

Pneumococcal vaccines in adults: Assessing the evolving evidence

(2011) John D. Grabenstein et al.   VACCINE

Repeat revaccination with 23-valent pneumococcal polysaccharide vaccine among adults aged 55–74 years living in Alaska: No evidence of hyporesponsiveness☆☆☆

(2011) Laura L. Hammitt et al.   VACCINE

Serotype changes in adult invasive pneumococcal infections in Portugal did not reduce the high fraction of potentially vaccine preventable infections

(2011) Andreia N. Horácio et al.   VACCINE

The Changing Epidemiology of Invasive Pneumococcal Disease in Aboriginal and Non‐Aboriginal Western Australians from 1997 through 2007 and Emergence of Nonvaccine Serotypes

(2010) Deborah Lehmann et al.   CLINICAL INFECTIOUS DISEASES

Pneumococcal Vaccination and Revaccination in the Elderly Population

(2010) Kristin L. Nichol   JOURNAL OF INFECTIOUS DISEASES

Safety and Antibody Response, Including Antibody Persistence for 5 Years, after Primary Vaccination or Revaccination with Pneumococcal Polysaccharide Vaccine in Middle‐Aged and Older Adults

(2010) Daniel M. Musher et al.   JOURNAL OF INFECTIOUS DISEASES

Revaccination with a 23‐Valent Pneumococcal Polysaccharide Vaccine Induces Elevated and Persistent Functional Antibody Responses in Adults Aged ⩾65 Years

(2010) Susan B. Manoff et al.   JOURNAL OF INFECTIOUS DISEASES

A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults

(2010) Neil French et al.   NEW ENGLAND JOURNAL OF MEDICINE

The current status of invasive pneumococcal disease in Poland

(2010) Anna Skoczyńska et al.   VACCINE

Changing Epidemiology of Invasive Pneumococcal Disease in Canada, 1998–2007: Update from the Calgary‐AreaStreptococcus pneumoniaeResearch (CASPER) Study

(2009) James D. Kellner et al.   CLINICAL INFECTIOUS DISEASES

Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine

(2009) Tamara Pilishvili et al.   JOURNAL OF INFECTIOUS DISEASES

National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: Emergence of serotype 19A with high invasive potential

(2009) Yu-Chia Hsieh et al.   VACCINE